GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Keymed Biosciences Inc (HKSE:02162) » Definitions » PB Ratio

Keymed Biosciences (HKSE:02162) PB Ratio : 3.34 (As of May. 15, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Keymed Biosciences PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-15), Keymed Biosciences's share price is HK$39.40. Keymed Biosciences's Book Value per Share for the quarter that ended in Dec. 2023 was HK$11.81. Hence, Keymed Biosciences's PB Ratio of today is 3.34.

The historical rank and industry rank for Keymed Biosciences's PB Ratio or its related term are showing as below:

HKSE:02162' s PB Ratio Range Over the Past 10 Years
Min: 1.19   Med: 3.06   Max: 5.75
Current: 3.34

During the past 5 years, Keymed Biosciences's highest PB Ratio was 5.75. The lowest was 1.19. And the median was 3.06.

HKSE:02162's PB Ratio is ranked worse than
62.65% of 1320 companies
in the Biotechnology industry
Industry Median: 2.52 vs HKSE:02162: 3.34

During the past 12 months, Keymed Biosciences's average Book Value Per Share Growth Rate was -12.20% per year.

Back to Basics: PB Ratio


Keymed Biosciences PB Ratio Historical Data

The historical data trend for Keymed Biosciences's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Keymed Biosciences PB Ratio Chart

Keymed Biosciences Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
- - 2.15 3.79 4.16

Keymed Biosciences Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only 2.15 2.16 3.79 3.07 4.16

Competitive Comparison of Keymed Biosciences's PB Ratio

For the Biotechnology subindustry, Keymed Biosciences's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Keymed Biosciences's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Keymed Biosciences's PB Ratio distribution charts can be found below:

* The bar in red indicates where Keymed Biosciences's PB Ratio falls into.



Keymed Biosciences PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Keymed Biosciences's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=39.40/11.809
=3.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Keymed Biosciences  (HKSE:02162) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Keymed Biosciences PB Ratio Related Terms

Thank you for viewing the detailed overview of Keymed Biosciences's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Keymed Biosciences (HKSE:02162) Business Description

Traded in Other Exchanges
Address
No. 18 BioTown Middle Road, Building D2, Tianfu International BioTown, Chengdu, Sichuan, CHN, 610219
Keymed Biosciences Inc is a biotechnology company with multiple clinical-stage assets. The company is focused on the in-house discovery and development of innovative biological therapies that address large underserved medical needs in the autoimmune and oncology therapeutic areas. The Group is engaged in biopharmaceutical research and development, which is regarded as a single reportable segment. Geographically, it operates in Hong Kong & Mainland China, out of which the majority is from Mainland China.

Keymed Biosciences (HKSE:02162) Headlines

No Headlines